Sign in
4

Changes in Ownership

IRONWOOD PHARMACEUTICALS INC Filed Acc 0000950170-24-029906

CMO,SVP,Head-Res&Drug acquired 34,936 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Shetzline Michael CMO,SVP,Head-Res&Drug 2024-03-08 Option exercise +34,936 429,847 D
Derivatives
Shetzline Michael CMO,SVP,Head-Res&Drug 2024-03-08 Option exercise · Performance-based Restricted Stock Unit −34,936 0 D
Loading xslF345X05/ownership.xml…